their primary role is induction of a negative energy balance
This is a high-risk population, and historically weve had limited data to guide treatment decisions, said Amy Sheer, M.D., M.P.H., an associate professor of medicine and director of the Obesity Medicine Fellowship program at the University of Florida in Gainesville, Florida
doi: 10.1007/s12325-017-0499-6 123 KalraSBhattacharyaSKapoorN
Drug companies developed the synthetic agonist, which helps the naturally occurring GLP-1 hormone bind to its receptor in the blood and stay in circulation longer
Keep your GLP-1 medication out of direct sunlight, like in a medication travel case
This makes it more targeted for fat loss without the broader effects on growth and IGF-1 levels